REFERENCES
Aguayo-Mazzacuto, C., Zavacki, A.M., Marinelarena, A., Hollisyer-Lock, J., El Khattabi, I. Marsili, A., Weir, G. C., Sharma, A., Larsen, P. R., & Bonner-Weir, S. (2013). Thyroid hormone promotes postnatal rat pancreatic β-cell development and glucose-responsive insulin secretion through MAFA. Diabetes , 62 , 1569-1580. Banik, B. L., & Brown, J. L. (2015). Interaction of responsive/switchable surfaces with cells. In Switchable and Responsive Surfaces and Materials for Biomedical Applications  (pp. 189-201). Elsevier Inc. Benthuysen, J. R., Carrano, A. C. & Sander, M. (2016). Advances in β cell replacement and regeneration strategies for treating diabetes.J. Clin. Invest. 126 (10), 3651–3660. Bosworth, L. A., Hu, W., Shi, Y. & Cartmell, S. H. (2019). Enhancing biocompatibility without compromising material properties: an optimised NaOH treatment for electrospun polycaprolactone fibers. J of Nanomat , 2019. Bruin, J. E., Rezania, A., Xu, J., Narayan, K., Fox, J. K., O’Neil, J. J. & Kieffer, T. J. (2013). Maturation and function of human embryonic stem cell-derived pancreatic progenitors in macroencapsulation devices following transplant into mice. Diabetologia , 56 , 1987-1998. Chang, E. A., Tomov, M. L., Suhr, S. T., Luo, J., Olmsted, Z. T., Paluh, J. L., Cibelli, J. (2015). Derivation of Ethnically Diverse Human Induced Pluripotent Stem Cell Lines. Sci Rep , 5 , 15234. Chen, F., Lee, C. N. & Teoh, S. H. (2007). Nanofibrous modification on ultra-thin poly(e-caprolactone) membrane via electrospinning. Mat sci & Eng C , 27 , 325-332. Courtenay, J. C., Sharma, R. I. & Scott, J. L. (2018) Recent Advances in Modified Cellulose for Tissue Culture Applications. Molecules ,23 , 654-674. Courtenay, J. C., Johns, M. A., Galenbeck, F., Deneke, C., Lanzoni, E. M., Costa, C. A., Scott, J. L. & Sharma, R. I. (2017). Surface modified cellulose scaffolds for tissue engineering. Cellulose , 24 , 253-267. D’Amour, K. A., Bang, A. G., Eliazer, S., Kelly, O. G., Agulnick, A. D., Smart, N. G., Moorman, M. A., Kroon, E., Carpenter, M. K. & Baetge, E. E. (2006). Production of pancreatic hormone – expressing endocrine cells from human embryonic stem cells. Nat Biotech ,24 (11), 1392–1401. Davidenko, N., Schuster, C. F., Bax, D. V., Farndale, R. W., Hamaia, S., Best, S. M. & Cameron, R. E. (2016). Evaluation of cell binding to collagen and gelatin: a study of the effect of 2D and 3D architecture and surface chemistry. J Mater Sci: Mater Med , 27 , 148-162. De Oliveira Barud, H. G., da Silva, R. R., da Silva Barud, H., Tercjak, A., Gutierrez, J., Lustri, W. R., de Oliveira Junior, O. R., Ribeiro, S. J. L. (2016). A multipurpose natural and renewable polymer in medical applications: bacterial cellulose. Carbohydrate Polymers ,153 , 406-420. Dhandayuthapani, B., Yoshida, Y., Maekawa, T. & Kumar D. S. (2011). Polymeric scaffolds in tissue engineering application: A review. Int J Polymer Sci, 2011. Enderami, SE., Soleimani, M., Mortazavi, Y., Naderi, S. & Salimi, A. (2018). Generation of insulin-producing cells from human adipose-derived mesenchymal stem cells on PVA scaffold by optimized differentiation protocol. J Cell phys , 233 (5), 4327-4337. Gervaso, F., Sannino, A. & Peretti, G. M. (2013). The biomaterialist’s task: scaffold biomaterials and fabrication technologies. Joints, 1(3), 130-137. Hammer, E., Parnaud, G., Bosco, D, Perriraz, N., Maedler, K., Donath, M., Rouiller, D. G. & Halban, P. A. (2004). Extracellular matrix protects pancreatic B-cells against apoptosis. Diabetes ,53 , 2034-2041. Herberts, C.A., Kwa, M. SG. & Hermsen, H. PH. (2011). Risk factors in the development of stem cell therapy. J. Trans. Med. 9 , 29-43. Jacobson, E. F. & Tzanakakis, E. S. (2017). Human pluripotent stem cell differentiation to functional pancreatic cells for diabetes therapies: Innovations, challenges and future directions. J. Biol. Eng.,11 , 21-34. Jiang, Y. & Chen, D. (2017). Stem Cell‑based Approach in Diabetes and Pancreatic Cancer Management. Cancer Transl Med , 3 (1), 34-8. Kaputis, T., Clough, D., Noto, F., Rychel, K., Dye, B. & Shea, L. D. (2018). Microporous polymer scaffolds for the transplantation of embryonic stem cell derived pancreatic progenitors to a clinically translatable site for treatment of type I diabetes. ASC Biomaterials , 4 , 1770-1778. Kempf, H., Andree, B. & Zweigerdt, R. (2016). Large-scale production of human pluripotent stem cell derived cardiomyocytes. Adv. Drug Deliv. Rev. 96, 18–30. Kieffer, T. J. (2016). Forum closing in on mass production of mature human beta cells. Cell Stem Cell , 18 , 699–702. Kieffer, T. J., Woltjen, K., Osafune, K., Yabe, D., & Inagaki, N. (2018). Beta-cell replacement strategies for diabetes. J Diabetes Investig , 9 (3), 457-463. Kim, Y., Kwon, I. K., & Shin, K. (2016). Extracellular matrix revisited: roles in tissue engineering. Int Neuronal J ,20 (S1), 23-29. Krishnamurthy, M., & Wang, R. (2009). Integrins and extracellular matrices in pancreatic tissue engineering. Frontier in Biosciences , S1 , 477-491. Kroon, E., Martinson, L. A., Kadoya, K., Bang, A. G., Kelly, O. G., Eliazer, S., Young, H., Richardson, M., Smart, N. G., Cunningham, J., Agulnick, A. D., D’Amour, K. A., Carpenter, M. K. & Baetge, E. E. (2008). Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat biotech , 26 (4), 443–453. Kropp, C., Massai, D. & Zweigerdt, R. (2017). Progress and challenges in large-scale expansion of human pluripotent stem cells. Process Biochem. 59 , 244–254. Kuo, Y., Liu, Y. & Rajesh, R. (2017). Pancreatic differentiation of induced pluripotent stem cells in activin A-grafted gelatin-poly(lactide-co-glycolide) nanoparticle scaffolds with induction of LY294002 and retinoic acid. Mat Sci & Eng C , 77 , 384-393. Le, X., Poinern, G. E. J., Ali, N., Berry, C. M., & Fawcett, D. (2013). Engineering a biocompatible scaffold with either micrometer or nanometer scale surface topography for promoting protein adsorption and cellular response. Int J Biomaterials , 2013. Llacua, L. A., Faas, M. M., de Vos, P. (2018). Extracellular matrix molecules and their potential contribution to the function of transplanted pancreatic islets. Diabetologia, 61 , 1261-1272. Mansour, R. N., Barati, G., Soleimani, M., Ghoraeian, P., Nouri-Aleagha, M., Kehtari, M., Mahboudi, H., Hosseini, F., Hasannia, H., Abazari, M. F. & Enderami, SE. (2018). Generation of high-yield insulin producing cells from human-induced pluripotent stem cells on polyethersulfone nanofibrous scaffold. Artif Cell Nanomed biotechnol , 46 , 733-739. Millman, J. R., & Pagliuca, F. W. (2017). Autologous pluripotent stem cell – derived β-like cells for diabetes cellular therapy.Diabetes , 66 , 1111–1120. Millman, J. R., Xie, C., Dervort, A. V., Gürtler, M., Pagliuca, F. W. & Melton, D. A. (2016). Generation of stem cell-derived b cells from patients with type 1 diabetes. Nat commun , 7 , 11463. Modulevsky, D. J., Lefebvre, C., Haase, K., Al-Rekabi, Z. & Pelling, A. E. (2014). Apple derived cellulose scaffold for 3D mammalian cell culture. Plos one , 9 (5), e97835. Okere, B., Luacaccioni, L., Dominici, M., & Lughetti, L. (2016). Cell therapies for pancreatic beta-cell replenishment. Italian J Pediatrics , 42, 62-71. Park, J. S., Kim, JM., Lee, S. J., Lee, S. G., Jeong, YK., Kim, S. E. & Lee, S. E. (2007). Surface hydrolysis of fibrous poly(ε-caprolactone) scaffolds for enhances osteoblast adhesion and proliferation.Macromolecular Research , 15 (5), 424-429. Park, S., Lee, J., Kim, Y., Kim, J., Il, K.K., Lee, J., Kim, W., Kim, H., Kim, M. & Lee, J. (2014). Effect of sodium hydroxide treatment on scaffold by solid freeform fabrication. Polymer Korea ,38 (6), 815-819. Rezania, A., Bruin, J. E., Riedel, M. J., Mojibian, M., Asadi, A., Xu, J., Gauvin, R., Narayan, K., Karanu, F., O’Neil, J. J., Ao, Z., Warnock, G. L. & Kieffer, T. J. (2012). Maturation of human embryonic stem cell–derived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice. Diabetes , 61 , 2016-2029. Rezania, A., Bruin, J. E., Arora, P., Rubin, A., Batushansky, I., Asadi, A., O’Dwyer, S., Quiskamp, N., Mojibian, M., Albrecht, T., Yang, Y. H. C., Johnson, J. D. & Kieffer, T. J. (2014). Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells. Nat Biotech , 32 (11), 1121-1133. Richbourg, N. R., Peppas, N. A. & Sikavitsas, V. I. (2019). Tuning the biomimetic behavior of scaffolds for regenerative medicine through surface modifications. J Tissue Eng Regen Med , 13 (8), 1275-1293. Russ, H. A., Parent, A.V., Ringler, J. J., Hennings, T. G., Nair, G. G., Shveyjert, M., Guo, T., Puri, S., Haataja, L., Cirulli, V., Blellock, R., Szot, G. L., Arvan, P. & Hebrok, M. (2015). Controlled induction of human pancreatic progenitors produces functional beta-like cells in vitro. The EMBO J , 34 , 1759–1772. Salvatori, M., Katari, R., Patel, T., Peloso, A., Mugweru, J., Owusu, K., & Orlando, G. (2014). Extracellular matrix scaffold technology for bioartificial pancreas engineering. J Diabetes Sci Technol ,8 (1), 159-169. Schulz, T. C., Young, H. Y., Agulnick, A. D., Babin, M. J., Baetge, E. E., Bang, A. G., Bhoumik, A., Cepa, I., Cesario, R. M., Haakmeester, C., Kadoya, K., Kelly, J. R., Kerr, J., Martinson, L. A., McLean, A. B., Moorman, M. A., Payne, J. K., Richardson, M., Ross, K. G., Sherrer, E. S., Song, X., Wilson, A. Z., Brandon, E. P., Green, C. E., Kroon, E. J., Kelly, O. G., D’Amour, K. A. & Robins, A. J. (2012). A Scalable system for production of functional pancreatic progenitors from human embryonic stem cells. PLOS One , 7 (5), e37004. Schulz, T. C. (2015). Concise Review: Manufacturing of pancreatic endoderm cells for clinical trials in type 1 diabetes. Stem Cells Transl. Med. 4 , 927–931. Smink, A. M., & De Vos, P. (2018). Therapeutic strategies for modulating the extracellular matrix to improve pancreatic islet function and survival after transplantation. Curr Diab Rep. 18 , 39-46. Stendahl, J.C., Kaufman, D. B. & Stupp, S. I. (2009). Extracellular matrix in pancreatic islets: Relevance to scaffold design and transplantation. Cell Trans . 18 , 1-12. Takahashi, Y., Takebe, T. & Taniguchi, H. (2016). Engineering pancreatic tissues from stem cells towards therapy. Regen. Ther.3 , 15–23. Tomov, M. L., Olmsted, Z. T., & Paluh, J. L. (2015). The human embryonic body cystic core exhibits architectural complexity revealed by use of high throughput polymer microarrays. Macromol. Biosci ,15 (7). Vegas, A. J., Veiseh, O., Gürtler, M., Millman, J.R., Pagliuca, F. W., Bader, A. R., Doloff, J. C., Li, J., Chen, M., Olejnik, K., Tam, H. H., Jhunjhunwala, S., Langan, E., Arestadasilva, S., Gandham, S., McGarrigle, J., Bochenek, M. A., Hollister-Lock, J., Obirholzer, J., Greiner, D. L., Weir, G. C., Melton, D. A., Langer, R. & Anderson, D. G. (2016). Long term glycemic control using polymer encapsulated, human stem-cell derived b-cells in immune competent mice. Nat Med ,22 (3), 306–311. Vieira, A., Courtney, M., Druelle, N., Avolio, F., Napolitano, T., Hadzic, B., Navarro-Sanz, S., Ben-Othman, N. & Collombat, P. (2016). β-Cell replacement as a treatment for type 1 diabetes: an overview of possible cell sources and current axes of research. Diabetes, Obes. Metab. 18 , 137–143. Wang, Y., Hai, T., Liu, L. & Zhou, Q. (2015). Cell therapy in diabetes: current progress and future prospects. Sci. Bull. 60(20) , 1744–1751. Wilmut, I., Leslie, S., Martin, N. G., Peschanski, M., Rao, M., Trounson, A., Turner, D., Turner, M. L., Yamanaka, S. & Taylor, C. J. (2015). Development of a global network of induced pluripotent stem cell halpobank. Reg. Med . 10 (3), 235-238.